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Abstract  
Background: Amphetamine (AT) is a potent central nervous system stimulant 
that is capable of producing damaging effects to the central dopaminergic 
pathway; used both for medical purposes and also abused recreationally. One 
of the potential naturally occurring compounds is thymoquinone (TQ), an 
active compound of Nigella sativa; which is known for its cellular protective 
effects. The objectives of this study were to determine the IC50 values of AT 
and TQ on differentiated SH-SY5Y neuronal cells and to evaluate the changes 
of dopamine (DA) level in the cells exposed to AT after co-administering with 
TQ.  
Materials and Methods: Differentiated SH-SY5Y cells were grown in a cell 
culture flask containing DMEM/F12 medium supplemented with 10% (v/v) 
fetal bovine serum and 1% (v/v) penicillin/streptomycin. The IC50 value of 
TQ and AT in differentiated SH-SY5Y cells was determined by using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The 
DA level was determined by using the Enzyme-Linked Immunosorbent Assay 
(ELISA) kit.  
Results: The IC50 values of AT and TQ were 1596 µM and 926 µM, 
respectively. Co-administration of 40 µM of AT and 30 µM of TQ 
demonstrated a significant increase in DA level at 48 hours of exposure when 
compared to the administration of AT group (P≤0.05).  
Conclusion: These findings suggested that TQ has a role in maintaining the 
DA activity after long-term AT exposure.  
Keywords: amphetamine, thymoquinone, differentiated SH-SY5Y cells, 
dopamine, lactate dehydrogenase activity 
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Amphetamine (AT) is a potent central nervous system 
stimulant that belongs to the psychoactive drugs group. 
It has been used as a treatment for several disorders 
such as attention deficit hyperactivity disorder 
(ADHD), narcolepsy, depression, and minor obesity 
(1). However, the illegal use of AT has gained 
popularity as a recreational drug among youths and 
teenagers due to its psychostimulant effects (2).  
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Administration of AT causes elevation of 
dopamine (DA) levels in the body. DA is a primary 
neurotransmitter involved in reward pathways for 
movement regulation, working memory, and euphoric 
effects (3,4). The elevation of DA level causes the DA 
systems to become dysfunctional and leads to DA 
depletion after a long-term AT exposure (5). The 
damaging effects of AT administration will be 
manifested as restless sleep, mood swings, and 
depression (6) as well as anxiety and fatigue (7). 
Overdose and uncontrollable consumption of AT will 
also lead to several medical disorders such as heart and 
kidney problems, increased risk of stroke, and 
neurotoxicity (6). 
Antipsychotic drugs such as butyrophenone and 
benzodiazepine are reported as the options for 
pharmacological treatment of AT adverse effects (8). 
Unfortunately, antipsychotic drugs are associated with 
neurological side effects, including acute 
extrapyramidal syndromes (parkinsonism, dystonias), 
sedation, and hypotension (9). Apart from looking into 
a modern biological treatment, natural traditional 
remedies are also an alternative solution in reducing 
the effects of a drug used (10). Natural traditional 
medicines are used by a lot of people worldwide who 
depend primarily on these alternative medicines as 
their method to sustain their healthcare (11). 
One of the sources of traditional medicines that 
has a high potential in treating several diseases is 
thymoquinone (TQ). TQ is a bioactive compound 
found in several plants including Nigella Sativa and 
Monarda fistulosa which provides multiple healthy 
medicinal properties (12,13,14,15). Previous studies 
discovered that TQ possessed antioxidant, anti-
inflammatory, anti-cancer, as well as neuroprotective 
properties (16,17). The TQ was found to have a 
neuroprotective effect on primary dopaminergic 
neuronal cells against 1-methyl-4-phenylpyridinium 
(MPP+) and rotenone toxicities by preserving the 
tyrosine hydroxylase (TH) immunoreactive cells, most 
likely via its antioxidant properties (18).  
Furthermore, TQ was found to affect 
neurotransmitters in counteracting the effect of arsenic 
(AS) induce toxicity. The TQ reduced the effects of AS 
by increasing the levels of DA, norepinephrine (NE), 
acetylcholine esterase (AChE), and decreased the 
levels of nitrite/nitrate (NO), serotonin (5-HT), lipid 
peroxidation (MDA), and tumor necrosis factor (TNF-
α). The TQ acted as an antioxidant in this event (19).  
Considering the benefits of TQ as described 
previously, this study was conducted to investigate the 
effects of TQ on the DA level in neuronal cells exposed 
to AT. For this purpose, the human neuroblastoma SH-
SY5Y cell line was used as this cell line expresses 
neuronal markers such as DA and DA transporter 
(DAT). It also expresses different neuron-specific 
proteins as possessed by mature neuronal cells after 
being induced to undergo differentiation using retinoic 
acid (20,21,22). Hence, the differentiated human 
neuroblastoma SH-SY5Y cell line is a suitable in vitro 
model to be used to study the effects of AT on neuronal 
cells after AT exposure. 
 
Methods 
Experimental Design: This study was an in vitro 
experimental laboratory study. The purpose of this 
study was to investigate the effects of TQ on the DA 
level in differentiated SH-SY5Y cells exposed to AT. 
This study was done at the Chemical Laboratory and 
Cell Culture Laboratory, Faculty of Medicine, 
University of Sultan Zainal Abidin (UniSZA). This 
study was divided into 3 phases. In phase 1 of the 
study, differentiation of SH-SY5Y cells was carried 
out and the IC50 values of TQ and AT in differentiated 
SH-SY5Y cells were determined by using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay.  
Three concentrations of AT and TQ were 
determined for the second phase of the study. In this 
phase, the DA level for the selected concentrations of 
AT and TQ was determined using Enzyme-Linked 
Immunosorbent Assay (ELISA) kit. One optimum 
concentration of AT and TQ was later be determined 
from the result for further study in phase 3. In the phase 
3 study, four experimental groups of differentiated SH-
SY5Y cells were used which comprised the control 
group, AT group, TQ group, and co-administration of 
AT and TQ group. The concentration of DA level for 
each group was measured after incubating the cells 
with respective substances for 3, 12, 24, and 48 hours 
(Jamil et al., 2013). Finally, statistical analysis was 
carried out using Graph Pad Prism 6. 
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Reagents and Chemicals: The SH-SY5Y cell line was 
purchased from American Type Culture Collection 
(ATCC), Virginia, USA. Dulbecco’s Modified Eagle 
Medium/F12 (DMEM/F12), fetal bovine serum (FBS), 
phosphate-buffered saline (PBS), neurobasal medium, 
B27 supplement, trypsin EDTA, glutaMAX, and 
penicillin/streptomycin were obtained from Gibco 
(Invitrogen, USA). Dimethyl sulfoxides (DMSO) were 
purchased from Merck (Germany). Thymoquinone 
(>99% purity), trypan blue, MTT powder were 
purchased from Sigma-Aldrich (USA). Retinoic acid 
(RA) was purchased from Nacalai Tesque, Japan, and 
amphetamine were purchased from Arlesheim, 
Switzerland. The dopamine ELISA kit was obtained 
from Elabscience, Texas, USA. 
Cell Culture Preparation and Differentiation of 
SH-SY5Y Cells: The SH-SY5Y cell line was grown in 
DMEM/F12 supplemented with 10% FBS and 1% 
penicillin/streptomycin. The media was changed every 
3 days and incubated at 37°C in a humidified 
atmosphere of 5% CO2. After the cells reached 70-
80% confluency, the growth media was discarded from 
the flask and was replaced with neurobasal medium 
(containing B27 supplement and GlutaMAX) and 10 
μM of RA to promote differentiation and neuronal 
phenotype for 5 days. The growth media was replaced 
every 48 hours. The differentiation of the cells was 
monitored microscopically for their morphological 
changes. Once the SH-SY5Y cells completed the 
differentiation, the cells exhibited long neurites with 
branched processes, reminiscent of dendrites or axons 
(23,24). 
Determination of IC50 Value by MTT Assay: 
Determination of IC50 values of TQ and AT was 
evaluated using MTT assay as previously described by 
Mosmann, (1983) (25). Briefly, 2×105cells/ml 2×105 
of cells in 100 µL growth media per well were seeded 
in a 96-well plate. Then, the well plate was incubated 
for 24 hours in 5% CO2 and the differentiation method 
was carried out as described previously. Following cell 
differentiation, serially diluted solutions of TQ (0, 95, 
190, 381, 761, 1523, 3045, and 6090 µM) and AT (0, 
116, 231, 462, 925, 1849, 3698, and 7396 µM) were 
prepared following the previous study from Al-Sheddi 
et al., (2014) (26). A 100 µL of each dilution was 
transferred to the cells in a 96-well plate and incubated 
for 72 hours. Subsequently, 20 µL of MTT (5 mg/mL) 
was added to the cells in the dark and incubated for 4 
hours, covered in aluminum foil. After the incubation, 
all the mixture in each well was removed and 100 µL 
of DMSO was added to each well to dissolve the 
formazan crystals formed. The absorbance was 
immediately read by using the Tecan ELISA 
microplate reader (Infinite M200 Pro) at a wavelength 
of 490 nm as a measurement wavelength and using 630 
nm as a reference wavelength. The potency of cell 
growth inhibition for the test agents was expressed as 
the half-maximal (50%) inhibitory concentration, 
IC50. Cell viability rate was calculated as the 
percentage of MTT absorption as follows (27):  
50% of maximal Inhibition = [(mean of experimental 
absorbance/mean of control absorbance x 100%] 
Cell Culture and Exposure to Amphetamine and 
Thymoquinone: Differentiated SH-SY5Y cell was 
used to measure the effect of TQ on the DA level. The 
SH-SY5Y cells were maintained in cell culture flask 
with DMEM/F12 medium containing 10% (v/v) FBS 
and 1% (v/v) pen/strep. The SH-SY5Y cells were 
grown as a monolayer in a humidified incubator 
supplemented with 5% CO2 at 37°C. Next, the cells 
were treated with AT and TQ to determine an optimum 
concentration for each substance. The measurement of 
DA level was carried out in phase 2 and phase 3 of the 
experiment as described previously. In phase 2 of the 
study, the result from the MTT assay was used to select 
the concentration below the IC50 value. Then, the 
range of safe concentration was determined to be used 
for the subsequent experiment. Firstly, the growth 
media was replaced with a fresh growth media 
containing the following concentrations of AT (10, 40, 
and 180 µM) and TQ (5, 30, and 150 µM). After that, 
DA level measurements for three concentrations of AT 
and TQ were conducted by incubating the 
differentiated SH-SY5Y cells for 3 hours (short-term 
effect) and 48 hours (long-term effect) (28). This step 
was done to demonstrate the DA level changes in the 
concentration of AT and TQ. One optimum 
concentration for each substance was determined from 
the result for further study in phase 3. Following that, 
phase 3 of the experiment was conducted with four 
experimental groups of differentiated SH-SY5Y cells 
comprising of the control group, AT group, TQ group, 
and co-administration of AT and TQ group. These 
groups were incubated for 3, 12, 24, and 48 hours 
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following Jamil et al., (2013) (29) with some 
modification before measuring the DA level from the 
supernatant. 
Measurement of Dopamine Level: All groups in 
phase 2 and phase 3 of the experimental design were 
assayed for the DA concentration after incubation in 
differentiated SH-SY5Y cells by using the ELISA kit. 
(Elabscience, Houston, Texas). The procedure for this 
assay was applied according to the commercially 
available protocol from the DA ELISA kit user 
manual. Briefly, the growth media of the cells was 
removed and the cells were washed with a moderate 
amount of pre-cooled PBS. After that, the cells were 
dissociated by using trypsin, and the cell suspension 
was collected into a centrifuge tube containing growth 
media. The cell suspension was later centrifuged at 
1000xg at 4°C for 5 minutes. The growth media was 
discarded and the cells were washed with pre-cooled 
PBS three times. Then, 1 mL of pre-cooled PBS was 
added to keep the cells in suspension and the cells in 
PBS were stored at -20°C. After two freeze-thaw 
cycles, the cell lysates were centrifuged at 1500xg at 
4°C for 10 minutes. The supernatant of the cell lysates 
was added to the biotinylated detection antibody Ab 
working solution. This mixture was incubated in 
antibody-coated wells for 45 minutes at 37°C. 
Subsequently, the solution from each well was 
aspirated and 350 µL of buffer was added to each well. 
The microplate was patted to dry using clean absorbent 
paper. This wash step was repeated 3 times. Next, 100 
µL Horseradish Peroxidase (HRP) conjugate was 
added to each well and incubated for 30 minutes at 
37°C. The wells were then washed 5 times using the 
same washing steps as described previously. A 90 µL 
substrate reagent was added to the wells in the next step 
and the wells were incubated for 15 minutes at 37°C. 
The reactions were stopped by adding 50 µL stop 
solution and the results were determined using a 
microplate reader set at 450 nm. 
Statistical Analysis: The determination of cell 
viability was calculated based on the measurement of 
wavelength at 490 nm and the reference wavelength of 
630 nm using non-linear regression analysis. Results 
were presented as mean ± standard error mean (SEM). 
For grouped comparison in investigating the DA level, 
statistical analysis was determined using a one-way 
analysis of variance (ANOVA) followed by Dunnet’s 
multiple comparisons test. P-value of less than 0.05 
was considered as statistically significant. All the data 
were presented graphically in the form of graph and 
figure using a computer software program of Graph 




The IC50 Values of Thymoquinone and 
Amphetamine in Differentiated SH-SY5Y Cells: 
Following the MTT assay, the dose-response curve 
was prepared by plotting the percentage of viable cells 
against the concentration of the compound. As shown 
in Figure 1(a) and (b), the IC50 values for TQ and AT 
were 926 µM and 1596 µM respectively. From this 
result, the range of concentrations below the IC50 
values required for the subsequent experiment was 
identified. The AT concentrations of 10, 40, and 180 
µM (1, 5, and 25 µg/mL) and TQ concentrations of 5, 
30, and 150 µM (1, 5, and 25 µg/mL) were chosen as 
these concentrations showed cell viability of nearly 
100% and less affected by the treatment (29). 
Determination of Optimum Concentration of 
Thymoquinone on Dopamine level: for 
determination of the optimum concentration of 
amphetamine on dopamine level, the analysis was 
conducted to determine an optimum concentration of 
AT and TQ in differentiated SH-SY5Y cells. This 
analysis was carried out to observe and validate the 
optimum concentration of AT and TQ that cause an 
optimum increase in DA level in the cells. 
Differentiated SH-SY5Y cells were exposed to three 
different concentrations of AT (10, 40, and 180 µM) 
and TQ (5, 30, and 150 µM) for 3 hours and 48 hours. 
The result showed that at 3 hours of incubation, AT 
concentrations of 40 and 180 µM produced a 
significant increase in DA level compared to the 
control group (P≤0.05).  
Whereas, at 48 hours of incubation all 
concentrations of AT (10, 40, and 180 µM) showed a 
significantly decreased level of DA (P≤0.05) (P≤0.01). 
Thus, the AT concentration of 40 µM was chosen for 
the subsequent analysis as the concentration 
significantly increased the DA level after the short-
term effect (3 hours) and significantly caused DA level 
depletion after the long-term effect (48 hours) 
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compared to the control group (Oliveira et al.). The 
percentage of DA level changes (decrease) between 3 
hours and 48 hours after exposure to 40 µM of AT is 
also high (51%) (Figure 2). 
Determination of Optimum Concentration of 
Thymoquinone on Dopamine level: A further 
experiment was conducted to investigate the optimum 
concentration of TQ on the DA level. Exposure of cells 
to TQ for 3 hours exhibited an increased level of DA 
in all groups compared to the control group, although 
the difference in the level is not significant among the 
treated groups. Cell exposure to TQ for 48 hours 
showed no significant changes in the level of DA 
compared to groups exposed to TQ within 3 hours of 
exposure (Figure 3). This indicated that TQ does not 
produce damaging effects on the DA system. Since 
there is no significant difference in the level among the 
different concentrations of TQ, a concentration of 30 
 
Figure 1. The IC50 values of AT (a) and TQ (b) in differentiated SH-SY5Y cells. The cells were exposed to series of AT 
(0-7400 µM) and TQ (0-6100 µM) concentrations and incubated for 72 hours. The IC50 values of TQ and AT were 926 
µM and 1596 µM respectively. Data represent the mean ± SEM of three independent experiments. 
 
Figure 2. Dose-Response Effect of Amphetamine on 
Dopamine Level in Differentiated SH-SY5Y Cells at 3 
and 48 hours of incubation. Statistical analysis was 
carried out using One-way ANOVA Followed by 
Dunnet's Multiple Comparisons Test. *P≤0.05 vs 
Control Group, **P≤0.01 vs 3 Hours Group. 
 
Figure 3. Dose-Response Effect of Thymoquinone on 
Dopamine Level in Differentiated SH-SY5Y Cells at 3 
and 48 Hours of Incubation. Statistical Analysis was 
Carried out Using One-way ANOVA Followed by 
Dunnet's Multiple Comparisons Test. 
 
Figure 4. The Changes in Dopamine Level Against the 
Time of Exposure in the Experimental Groups. 
Differentiated SH-SY5Y Cells were Exposed with 
Amphetamine (40 µM), Thymoquinone (30 µM) and 
Co-administration of Thymoquinone (30 µM) and 
Amphetamine (40 µM) for 3, 12, 24, and 48 hours. One-
Way Analysis of Variance (ANOVA) was Used to 
Determine the Significance between Groups Followed 
by Dunnet’s Multiple Comparisons test. *P≤0.01 vs 
Control Group, #P≤0.01 vs AT Group. 
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µM was chosen for subsequent analysis taking 
reference from a study by Babazadeh et al. (30). 
The Effect of Dopamine Level after Co-
Administration of Amphetamine and 
Thymoquinone: In this study, the effect of DA level 
following co-administration of TQ and AT was 
examined for 3, 12, 24, and 48 hours of incubation. To 
determine the effect of TQ in counteracting the 
depletion of dopamine levels produced by AT, 
differentiated SH-SY5Y cells were co-administrated 
with 40 µM of AT and 30 µM of TQ. Three other 
groups used in this study were the control group, AT 
group, and TQ group. For the control group, the pattern 
of the graph showed a slightly decreased DA level at 3 
hours and 12 hours of incubation. Later, it showed a 
slightly increasing level at 24 hours followed by a 
slightly decreasing level at 48 hours of incubation.  
 Exposure to AT significantly increased DA 
level at 3 hours of incubation (P≤0.05) compared to the 
control group. Later, it showed significantly decreasing 
levels of DA with the lowest seen at 48 hours of 
incubation when compared to the control group 
(P≤0.05). The percentage of DA level decrease 
between 3 hours and 48 hours is 51%. The 
administration of TQ showed an increasing level at 3 
hours of incubation. Later, it decreased at 12 hours of 
incubation. After 12 hours, it showed an increasing 
pattern until 48 hours of incubation. There is no 
significant difference in the DA level when compared 
to the control group. Co-administration of AT and TQ 
showed an increasing level at 3 hours of incubation and 
slightly decreased at 12 hours of incubation, but later, 
it showed a significant increase in DA level at 48 hours 
of incubation when compared to AT group (P≤0.05). 
The graph also showed that the pattern of DA level 
changes of this group (co-administration of AT and 
TQ) and the control group is similar (Figure 4). 
Discussion 
Amphetamine is a psychostimulant drug that affects 
the central nervous system by increasing alertness, 
energy, and euphoria as a result of an increase in DA 
concentration (31). Administration of AT caused an 
excessive accumulation of DA and produced hydroxyl 
and superoxide radicals that exert toxic effects on the 
cells (32). Illicit use of AT was reported to give a range 
of negative side effects on the body. Recently, several 
natural traditional remedies were reported to have 
therapeutic effects including thymoquinone. Previous 
studies demonstrated that TQ exerts a neuroprotective 
effect against MPP+ and rotenone toxicities on primary 
dopaminergic neuronal cells (18). TQ also has a role in 
suppressing oxidative stress and neuropathy in 
streptozotocin-induced diabetic rats by interacting with 
neurotransmitters as it preserved the norepinephrine 
and DA concentrations to control-like values (33). 
In the present study, the effects of TQ on the 
changes of DA level in differentiated SH-SY5Y cells 
exposed to AT were examined. Initially, the IC50 
values of TQ and AT were investigated in 
differentiated SH-SY5Y cells by using an MTT assay 
to determine the range of concentrations for both 
compounds which are going to be used in the 
subsequent analysis. The MTT assay is used to 
measure several viable cells following treatment by a 
certain compound and the procedure was originally 
established by Mosmann. The result showed that the 
IC50 values of TQ and AT were 926 µM and 1596 µM 
respectively. Therefore, the concentration of TQ and 
AT that were used for the subsequent experiment was 
chosen to be lower than these IC50 values so that 
enough viable cells were present for the experiment 
and the number of cell death due to the treated 
compounds were very minimal and could be ignored. 
Thus, a range of concentrations below the IC50 value 
of AT (10, 40, and 180 µM) and TQ (5, 30, and 150 
µM) were used for further analysis. Further 
investigation on the optimum concentration of AT and 
TQ on DA level concentration was conducted in this 
experiment. From the result, AT at a concentration of 
40 µM was chosen for the subsequent analysis as the 
concentration gives a significant increase in DA level 
after short-term exposure (3 hours) while the DA level 
was depleted after long-term exposure (48 hours) 
compared to the control group. The percentage of DA 
level changes (decrease) between 3 hours and 48 hours 
after exposure to 40 µM of AT is also high (51%). This 
finding corresponded with a result from previous 
studies that showed a depletion of DA level by about 
80% after long-term exposure to AT in PC-12 
dopaminergic neuronal cells (28).  
Although the exact mechanism of AT inducing 
the damaging effects remains to be elucidated, several 
studies suggested that it involves several factors. A 
study conducted by Hotchkiss and Gibb (34) revealed 
that DA depletion after AT exposure corresponded to 
reduced activity of tyrosine hydroxylase. The DA 
depletion was also associated with a decrease in the 
number of DAT and vesicular monoamine transporter 
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2 (35). Furthermore, another study revealed that AT 
caused elevation in DA release that leads to DAT 
saturation and eventually resulted in DA reduction 
(36,37,38). The exposure of AT was also associated 
with high production of reactive oxygen (ROS) and 
nitrogen species causing a depletion at DA level (39).  
Meanwhile, one optimum concentration of TQ 
on the DA level was determined to be used for the next 
experiment. Long-term TQ exposure at a concentration 
of 30 µM preventing a reduction in DA level after AT 
exposure when compared to the control group. This 
suggests that TQ can interact with the DA 
neurotransmitter system and protects the system from 
dysfunctioning. According to El-Shamy et al. (40), TQ 
potentially gives prominent effects to neurotransmitter 
changes after long-term exposure to nicotine as it 
restored almost all monoamine neurotransmitters 
including DA, 5-HT, and NE to a value near to the 
control group. Another study revealed that long-term 
exposure to TQ can protect primary dopaminergic 
cultured neurons as it significantly increased the 
number of neurons by 83 to 100% after exposure to 
MPP+ and rotenone (18). Hence, by considering a 
concentration of TQ that was also used in a previous 
study by Babazadeh et al., 30 µM of TQ concentration 
was chosen for further analysis of its effects. The effect 
of co-administration of AT and TQ on the DA level 
was investigated in this present study. In our 
knowledge, these findings provide the first evidence of 
the TQ effect on the changes in DA level after exposure 
to AT. The result demonstrated that 30 µM TQ 
potentially prevents depletion in the DA level after the 
administration of 40 µM AT. It restores the DA level 
to almost the value of the control group. Thus, TQ has 
a role to maintain DA activity after exposure to AT. 
This is due to the properties of TQ that have the 
capability as scavengers for free radicals or oxidative 
stress agents (41). 
Oxidative stress is associated with depletion at 
the DA level (42). The purpose of this study is to 
investigate the TQ potential to counteract the effect of 
AT exposure. As mentioned by a study from Mansour 
et al., (43) TQ can act as a free radical scavenger 
including attenuating the ROS through its antioxidant 
properties. In the same way, TQ attenuated the ROS 
generation induced by beta-amyloid peptides in 
cultured hippocampal neurons (44). Supporting the 
explanation, a study from Badary et al. (45) reported 
that TQ also has a great capability to alleviate iron-
dependent microsomal lipid peroxidation. The lipid 
peroxidation acts as an agent that promotes oxidative 
stress in an in vitro study. This event may be correlated 
with the ability of TQ to cross the physiological barrier 
and get access to cellular components, which then act 
as a radical scavenger (45,46). Besides that, Kassab 
and El-Hennamy demonstrated an antioxidant action of 
TQ against AS by reducing lipid peroxidase and MDA 
levels. Furthermore, it has been shown that pre-
treatment with TQ effectively inhibited the degradation 
of antioxidant enzyme systems including superoxide 
dismutase (SOD), catalase (CAT), and glutathione 
peroxidase in the red blood cells of rats (47). The TQ 
was reported to prevent inhibition of antioxidant 
enzymes, SOD, and CAT, as suggested by a study from 
Cobourne-Duval et al. (48), inactivated BV-2 murine 
microglial cell lines. They also found that an increase 
in antioxidant enzyme activity after TQ treatment in 
the PC-12 cell line exposed to amyloid β-peptide (49). 
Thus, the present result suggested that TQ protects 
against neurotransmitter depletion due to its 
antioxidant properties. The TQ enhances dopaminergic 
function by preventing the overproduction of free 
radicals or oxidative stress agents and attenuated 
degradation of antioxidant enzyme systems. 
Conclusion 
In summary, these findings concluded that TQ prevents 
long term DA depletion in neuronal cells after long 
term exposure to 40 µM of AT. The findings also 
provide information on the effects of TQ for the 
prevention of neuronal damage caused by AT 
exposure. Hence, further study is recommended to 
discover detailed mechanisms of neuroprotection of 
TQ following AT exposure. 
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